BIOPROGNOSTIC Trademark

Trademark Overview

On Monday, July 12, 2021, a trademark application was filed for BIOPROGNOSTIC with the United States Patent and Trademark Office. The USPTO has given the BIOPROGNOSTIC trademark a serial number of 90822243. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, December 2, 2023. This trademark is owned by Renalytix AI, Inc.. The BIOPROGNOSTIC trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease
bioprognostic

General Information

Serial Number90822243
Word MarkBIOPROGNOSTIC
Filing DateMonday, July 12, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, December 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkBIO PROGNOSTIC
Goods and ServicesMedical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code044
First Use Anywhere DateThursday, September 30, 2021
First Use In Commerce DateThursday, September 30, 2021

Trademark Owner History

Party NameRenalytix AI, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events

Event DateEvent Description
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, December 2, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, December 2, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 13, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, July 13, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 20, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2023USE AMENDMENT ACCEPTED
Tuesday, March 14, 2023AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, March 14, 2023USE AMENDMENT FILED
Monday, March 13, 2023TEAS AMENDMENT OF USE RECEIVED
Monday, March 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 12, 2022NON-FINAL ACTION E-MAILED
Monday, September 12, 2022NON-FINAL ACTION WRITTEN
Thursday, August 11, 2022ASSIGNED TO EXAMINER
Tuesday, July 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 6, 2022NON-FINAL ACTION E-MAILED
Thursday, January 6, 2022NON-FINAL ACTION WRITTEN
Monday, January 3, 2022ASSIGNED TO EXAMINER
Wednesday, November 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 17, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 15, 2021NEW APPLICATION ENTERED

Related Keywords

bioprognostic heart medical liver kidney possible disease diagnoses therapies range associated